Kyongbo Pharmaceutical Co., Ltd (KRX:214390)

Kyongbo Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	132,444	148,701	200,579	239,069	256,999	390,877
Market Cap Growth	-25.86%	-25.86%	-16.10%	-6.98%	-34.25%	97.94%
Enterprise Value	217,749	236,571	278,339	290,819	317,767	437,346
Last Close Price	5540.00	6220.00	8333.62	9873.46	10553.94	15976.08
PE Ratio	28.56	32.05	67.44	391.54	-	41.56
PS Ratio	0.56	0.62	0.93	1.22	1.51	1.82
PB Ratio	0.91	1.02	1.39	1.66	1.76	2.51
P/TBV Ratio	0.93	1.05	1.43	1.70	1.81	2.56
P/FCF Ratio	-	-	-	-	556.60	44.73
P/OCF Ratio	888.19	997.21	41.41	23.61	14.30	18.80
EV/Sales Ratio	0.91	0.99	1.29	1.48	1.86	2.03
EV/EBITDA Ratio	10.13	10.35	16.14	21.82	51.82	20.58
EV/EBIT Ratio	23.99	22.63	50.20	208.82	-	50.49
EV/FCF Ratio	-17.35	-	-	-	688.22	50.05
Debt / Equity Ratio	0.63	0.63	0.53	0.45	0.39	0.41
Debt / EBITDA Ratio	4.00	4.00	4.40	4.84	9.23	2.98
Debt / FCF Ratio	-	-	-	-	122.55	7.24
Asset Turnover	0.87	0.87	0.85	0.82	0.70	0.88
Inventory Turnover	1.94	1.94	2.40	2.65	2.27	2.63
Quick Ratio	0.44	0.44	0.53	0.61	0.59	0.79
Current Ratio	1.15	1.15	1.15	1.22	1.25	1.47
Return on Equity (ROE)	3.19%	3.19%	2.07%	0.42%	-4.97%	6.16%
Return on Assets (ROA)	2.38%	2.38%	1.37%	0.36%	-1.69%	2.21%
Return on Capital (ROIC)	2.85%	2.85%	1.62%	0.42%	-1.96%	2.55%
Return on Capital Employed (ROCE)	6.90%	6.90%	3.70%	1.00%	-	5.40%
Earnings Yield	3.50%	3.12%	1.48%	0.26%	-2.92%	2.41%
FCF Yield	-9.47%	-8.44%	-2.42%	-1.15%	0.18%	2.24%
Payout Ratio	25.77%	25.77%	40.19%	195.77%	-	25.42%
Buyback Yield / Dilution	0.30%	0.30%	-0.34%	-0.15%	0.25%	-0.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.